Skip to content
10-Q

Quarterly Report

GUIDED THERAPEUTICS INC GTHP

0001477932-25-003835

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 13, 2025 78.91M sh
Stock Issued Q1 2025 · Mar 31, 2025 12.84M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $5.9M
Current Liabilities Q1 2025 · Dec 31, 2024 $6.16M
Total Liabilities Q1 2025 · Mar 31, 2025 $6M
Total Liabilities Q1 2025 · Dec 31, 2024 $6.27M
Current Assets Q1 2025 · Mar 31, 2025 $811K
Current Assets Q1 2025 · Dec 31, 2024 $1.2M
Total Assets Q1 2025 · Mar 31, 2025 $967K
Total Assets Q1 2025 · Dec 31, 2024 $1.38M
Shares Diluted restated Q1 2025 · Mar 31, 2024 54.75M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$100K
Stockholders Equity restated Q1 2025 · Mar 31, 2024 −$4.01K
Stockholders Equity restated Q1 2025 · Dec 31, 2023 −$3.81K
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.01
Eps Basic Q1 2025 · Mar 31, 2024 −$0.01
Sga Expense Q1 2025 · Mar 31, 2024 $236K
Rd Expense Q1 2025 · Mar 31, 2024 $54K
Net Income restated Q1 2025 · Mar 31, 2024 −$402
Operating Income Q1 2025 · Mar 31, 2024 −$359K
Gross Profit Q1 2025 · Mar 31, 2024 $4K
Revenue Q1 2025 · Mar 31, 2024 $6K